These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 34882360)

  • 1. The phytochemical plumbagin reciprocally modulates osteoblasts and osteoclasts.
    Yadav AM; Bagade MM; Ghumnani S; Raman S; Saha B; Kubatzky KF; Ashma R
    Biol Chem; 2022 Jan; 403(2):211-229. PubMed ID: 34882360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pitavastatin prevents ovariectomy-induced osteoporosis by regulating osteoclastic resorption and osteoblastic formation.
    Cheon YH; Lee CH; Kim S; Park GD; Kwak SC; Cho HJ; Kim JY; Lee MS
    Biomed Pharmacother; 2021 Jul; 139():111697. PubMed ID: 34243614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. WHI-131 Promotes Osteoblast Differentiation and Prevents Osteoclast Formation and Resorption in Mice.
    Cheon YH; Kim JY; Baek JM; Ahn SJ; Jun HY; Erkhembaatar M; Kim MS; Lee MS; Oh J
    J Bone Miner Res; 2016 Feb; 31(2):403-15. PubMed ID: 26255791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plumbagin, a Biomolecule with (Anti)Osteoclastic Properties.
    Sultanli S; Ghumnani S; Ashma R; Kubatzky KF
    Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33803472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GIP reduces osteoclast activity and improves osteoblast survival in primary human bone cells.
    Hansen MS; Søe K; Christensen LL; Fernandez-Guerra P; Hansen NW; Wyatt RA; Martin C; Hardy RS; Andersen TL; Olesen JB; Hartmann B; Rosenkilde MM; Kassem M; Rauch A; Gorvin CM; Frost M
    Eur J Endocrinol; 2023 Jan; 188(1):. PubMed ID: 36747334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular ROS tolerance determines the effect of plumbagin on osteoclast differentiation.
    Sultanli S; Schneider J; Burkart SS; Binder M; Kubatzky KF
    FASEB J; 2023 Dec; 37(12):e23293. PubMed ID: 37950627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rheumatoid Arthritis in the View of Osteoimmunology.
    Auréal M; Machuca-Gayet I; Coury F
    Biomolecules; 2020 Dec; 11(1):. PubMed ID: 33396412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Novel Rhein Derivative Modulates Bone Formation and Resorption and Ameliorates Estrogen-Dependent Bone Loss.
    Jiang M; Wang T; Yan X; Liu Z; Yan Y; Yang K; Qi J; Zhou H; Qian N; Zhou Q; Chen B; Xu X; Xi X; Yang C; Deng L
    J Bone Miner Res; 2019 Feb; 34(2):361-374. PubMed ID: 30320929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plumbagin Ameliorates Collagen-Induced Arthritis by Regulating Treg/Th17 Cell Imbalances and Suppressing Osteoclastogenesis.
    Wang T; Qiao H; Zhai Z; Zhang J; Tu J; Zheng X; Qian N; Zhou H; Lu E; Tang T
    Front Immunol; 2018; 9():3102. PubMed ID: 30671063
    [No Abstract]   [Full Text] [Related]  

  • 10. Current perspectives on the multiple roles of osteoclasts: Mechanisms of osteoclast-osteoblast communication and potential clinical implications.
    Daponte V; Henke K; Drissi H
    Elife; 2024 Apr; 13():. PubMed ID: 38591777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogen and testosterone use different cellular pathways to inhibit osteoclastogenesis and bone resorption.
    Michael H; Härkönen PL; Väänänen HK; Hentunen TA
    J Bone Miner Res; 2005 Dec; 20(12):2224-32. PubMed ID: 16294275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Streptococcus gordonii induces bone resorption by increasing osteoclast differentiation and reducing osteoblast differentiation.
    Park OJ; Kim J; Kim HY; Kwon Y; Yun CH; Han SH
    Microb Pathog; 2019 Jan; 126():218-223. PubMed ID: 30414445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The TRPV1 ion channel antagonist capsazepine inhibits osteoclast and osteoblast differentiation in vitro and ovariectomy induced bone loss in vivo.
    Idris AI; Landao-Bassonga E; Ralston SH
    Bone; 2010 Apr; 46(4):1089-99. PubMed ID: 20096813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A vitronectin-derived peptide reverses ovariectomy-induced bone loss via regulation of osteoblast and osteoclast differentiation.
    Min SK; Kang HK; Jung SY; Jang DH; Min BM
    Cell Death Differ; 2018 Feb; 25(2):268-281. PubMed ID: 28937683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psoralidin, a prenylated coumestan, as a novel anti-osteoporosis candidate to enhance bone formation of osteoblasts and decrease bone resorption of osteoclasts.
    Zhai Y; Li Y; Wang Y; Cui J; Feng K; Kong X; Chen L
    Eur J Pharmacol; 2017 Apr; 801():62-71. PubMed ID: 28283388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Shikonin relieves osteoporosis of ovariectomized mice by inhibiting RANKL-induced NF-κB and NFAT pathways.
    Chen Y; Xie Z; Zhang Y; Xia C; Yang M; Hu X
    Exp Cell Res; 2020 Sep; 394(1):112115. PubMed ID: 32473224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone as a Target Organ in Rheumatic Disease: Impact on Osteoclasts and Osteoblasts.
    Baum R; Gravallese EM
    Clin Rev Allergy Immunol; 2016 Aug; 51(1):1-15. PubMed ID: 26411424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Osteoblast and osteoclast crosstalks: from OAF to Ephrin.
    Tamma R; Zallone A
    Inflamm Allergy Drug Targets; 2012 Jun; 11(3):196-200. PubMed ID: 22280242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Catabolic activity of osteoblast lineage cells contributes to osteoclastic bone resorption
    Pirapaharan DC; Olesen JB; Andersen TL; Christensen SB; Kjærsgaard-Andersen P; Delaisse JM; Søe K
    J Cell Sci; 2019 May; 132(10):. PubMed ID: 30975918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Communication factors-promising targets in osteoporosis treatment.
    Zhang Y; Liu P; Li J; Li K; Teng Y; Wang X; Li X
    Curr Drug Targets; 2014 Feb; 15(2):156-63. PubMed ID: 23919828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.